Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
AuthID
P-00Y-DV3
P-00Y-DV3
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service